Literature DB >> 31466535

Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing Clostridioides difficile risk.

Matthew J Ziegler1, Craig Freyer2, Daniel Landsburg3, David Pegues1,4, Warren Bilker5, Rebecca Hirsh3, Colleen Kucharczuk3, Cheryl Gilmar4, Theresa Gorman3, Melissa Palmer3, Christina Harker3, Erin Lightheart6, Jennifer H Han1,4,5.   

Abstract

We implemented a guideline for appropriate acid suppressant use in hematology-oncology patients. This intervention resulted in a sustained reduction in proton pump inhibitor (PPI) use without an increase in rates of gastrointestinal bleeding. Practice guidelines are effective in reducing PPI use, which is associated with risk of Clostridioides difficile infection.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31466535      PMCID： PMC6893867          DOI： 10.1017/ice.2019.238

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.

Authors:  S Sartori; L Trevisani; I Nielsen; D Tassinari; I Panzini; V Abbasciano
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

Authors:  Chun Shing Kwok; Aaron Kobina Arthur; Chukwudubem Ifeanyichukwu Anibueze; Sonal Singh; Rodrigo Cavallazzi; Yoon Kong Loke
Journal:  Am J Gastroenterol       Date:  2012-04-24       Impact factor: 10.864

3.  Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.

Authors:  Sailajah Janarthanan; Ivo Ditah; Douglas G Adler; Murray N Ehrinpreis
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

4.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

Review 5.  Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use.

Authors:  Gianmauro Numico; Vittorio Fusco; Pierfrancesco Franco; Fausto Roila
Journal:  Crit Rev Oncol Hematol       Date:  2017-02-03       Impact factor: 6.312

6.  Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.

Authors:  Rebekah A Wahking; Randal L Steele; Rachel E Hanners; Sean M Lockwood; Kelly W Davis
Journal:  Hosp Pharm       Date:  2017-12-13

7.  Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.

Authors:  Sara Lynn Revolinski; L Silvia Munoz-Price
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

8.  Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results.

Authors:  Matthew Ziegler; Daniel Landsburg; David Pegues; Kevin Alby; Cheryl Gilmar; Kristen Bink; Theresa Gorman; Amy Moore; Brittaney Bonhomme; Jacqueline Omorogbe; Dana Tango; Pam Tolomeo; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2018-04-25       Impact factor: 3.254

9.  Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.

Authors:  Robert MacLaren; Paul M Reynolds; Richard R Allen
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

10.  Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback.

Authors:  Christopher E Kandel; Suzanne Gill; Janine McCready; John Matelski; Jeff E Powis
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090
  10 in total
  2 in total

1.  "Get Me Off This Medication!": A Comparison Between Gastroenterology and Primary Care Regarding Patient's Perceptions of Proton Pump Inhibitor Therapy.

Authors:  Raja Samir Khan; Yousaf Hadi; Swapna Gayam
Journal:  Cureus       Date:  2020-10-25

2.  Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.

Authors:  Devada Singh-Franco; David R Mastropietro; Miriam Metzner; Michael D Dressler; Amneh Fares; Melinda Johnson; Daisy De La Rosa; William R Wolowich
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.